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BASIC RESEARCH ARTICLE
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Nijmegen, The Netherlands; cAcademic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam and VU University Amsterdam,
Amsterdam, The Netherlands; dSchool of Health Sciences, University of Salford, Manchester, UK; eInstitute of Health and Society,
University of Worcester, Worcester, UK
ABSTRACT
Background: There is a widely-held belief in the trauma field that the presence of disso-
ciative symptoms is associated with poor treatment response. However, previous research
on the effect of dissociation in treatment outcomes pertained to specific patients and
trauma populations.
Objective: To test the hypothesis that the presence of the dissociative subtype of PTSD (DS)
would have a detrimental effect on the outcome of an intensive trauma-focused treatment
programme.
Methods: PTSD symptom scores (Clinician Administered PTSD Scale [CAPS] and PTSD
Symptom Scale Self-Report [PSS-SR]) were analysed using the data of 168 consecutive
patients (70.6% female) who had been exposed to a wide variety of multiple traumas,
including childhood sexual abuse, and of whom 98.2% were diagnosed with severe PTSD
(CAPS > 65). Most of them suffered from multiple comorbidities and 38 (22.6%) met the
criteria for DS. They took part in an intensive trauma-focused treatment programme for
PTSD. Pre- and post-treatment differences were compared between patients with and
without DS.
Results: Large effect sizes were achieved for PTSD symptom reduction on CAPS and the
PSS-SR, both for patients with DS and those without. Although patients with DS showed
a significantly greater PTSD symptom severity at the beginning, and throughout, treat-
ment, both groups showed equal reductions in PTSD symptoms. Of those who met the
criteria for DS, 26 (68.4%) no longer fulfilled the criteria for this classification after
treatment.
Conclusion: The results provide no support for the notion that the presence of DS nega-
tively impacts trauma-focused treatment outcomes. Accordingly, PTSD patients with DS
should not be denied effective trauma-focused treatments.
La presencia del subtipo disociativo de TEPT no modera el resultado
del Tratamiento Intensivo Centrado en el Trauma para el TEPT
Introducción: Existe una creencia generalizada en el campo del trauma de que la
presencia de síntomas disociativos se asocia con una peor respuesta al tratamiento. Sin
embargo, las investigaciones previas sobre el efecto de la disociación en los resultados
del tratamiento se han realizado con pacientes y poblaciones de trauma específicos.
Objetivo: probar la hipótesis de que la presencia del subtipo disociativo de TEPT (SD)
tendría un efecto perjudicial sobre el resultado de un programa de tratamiento intensivo
centrado en el trauma.
Métodos: se analizaron las puntuaciones de síntomas de TEPT (CAPS y PSS-SR) utilizando los
datos de 168 pacientes consecutivos (70,6% mujeres), que habían estado expuestos a una
amplia variedad de traumas múltiples, incluido el abuso sexual infantil, y de los cuales 98,2%
fueron diagnosticado con TEPT severo (CAPS > 65). La mayoría sufría de múltiples comorbi-
lidades y 38 (22,6%) cumplían los criterios para el SD. Estos pacientes participaron en un
programa de tratamiento intensivo centrado en el trauma para el TEPT. Las diferencias pre y
post tratamiento se compararon entre los pacientes con y sin SD.
Resultados: Se obtuvieron considerables tamaños del efecto para la reducción de los
síntomas de TEPT en el CAPS y el PSS-SR, tanto para los pacientes que experimentan SD
como los que no. Aunque los pacientes con el SD mostraron una gravedad de síntomas de
TEPT significativamente mayor al inicio, y durante todo el tratamiento, ambos grupos
mostraron reducciones semejantes en los síntomas de TEPT. De los participantes que
cumplían criterios para el SD, el 26 (68.4%) ya no cumplían dichos criterios para esta
clasificación después del tratamiento.
Conclusión: Los resultados no respaldan la idea de que la presencia del SD tenga un impacto
negativo en los resultados del tratamiento centrado en el trauma. En consecuencia, no se les debe
negar a los pacientes con TEPT con SD tratamientos efectivos centrados en el trauma.
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HIGHLIGHTS
• Patients with the
dissociative subtype of PTSD
(DS) differed from those not
having DS in the severity of
PTSD levels.
• DS and non-DS patients
showed similar levels of
improvement after trauma-
focused therapy.
• Intensive treatment
programmes can be quite
effective even for patients
with high levels of
dissociation.
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PTSD分离亚型的存在不会调节创伤后集中治疗PTSD的结果
背景：创伤领域普遍认为，分离症状的存在与治疗反应不佳有关。 然而，以前关于分离
治疗结果影响的研究涉及的是特定的患者和创伤人群。
目的：检验PTSD（DS）分离亚型会对以创伤为中心的强化治疗计划的结果产生不利影响
的假设。
方法：使用168名持续患者（70.6％女性）的数据分析PTSD症状评分（CAPS和PSS-SR）。这
些患者曾暴露于多种创伤包括儿童期性虐待，其中98.2％被诊断为严重PTSD（CAPS>
65）。他们中的大多数患有多种合并症，38名（22.6％）符合DS的标准。 他们参加了针对
PTSD的强化创伤治疗计划。对治疗前和治疗后不同DS患者之间的差异进行比较。
结果：对于DS患者和无DS患者，CAPS和PSS-SR 显示PTSD症状呈现效应量较大的减轻。
虽然DS患者在开始和整个治疗过程中表现出显着更严重的PTSD症状，但两组均表现出
PTSD症状相同程度的减少。 在达到DS标准的人群中，有26人（68.4％）在治疗后不再符
合该分类标准。
结论：结果不支持DS的存在对创伤治疗结果产生负面影响的观点。 因此，具有DS的PTSD
患者不应该被拒绝接受有效的以创伤为中心的治疗。
1. Introduction
Posttraumatic stress disorder (PTSD) is a highly burden-
some mental disease, severely impacting the life of
patients and their surroundings, as well as society in
general (Calhoun, Beckham, & Bosworth, 2002; Kessler,
2000). According to international guidelines, trauma-
focused psychotherapies (TFPs) are the first-choice treat-
ments for PTSD (National Institute for Health and
Clinical Excellence, 2005; World Health Organization,
2013). Recent meta-analyses show that TFPs are more
likely to be effective in the treatment of PTSD than non-
TFPs and psychopharmacological treatments, as the core
of PTSD symptomatology is being targeted rather than
merely blunting the expression of PTSD symptoms
(Cusack et al., 2016; Lee et al., 2016). Of all TFPs,
exposure-based cognitive behavioural therapies (e.g. pro-
longed exposure; Foa, Hembree, & Rothbaum, 2007) and
eyemovement desensitization and reprocessing (EMDR)
therapy (Shapiro, 2001) have the strongest evidence base
(Watts et al., 2013; World Health Organization, 2013).
Yet, when it comes to effectiveness, there is room for
improvement. For example, a meta-analysis by Bradley,
Greene, Russ, Dutra, and Westen (2005) indicated that
33% of the patients still meet the criteria of PTSD after
completing some form of trauma-focused treatment.
Another study found that up to 15% of those who
developed PTSD were not likely to recover following
treatment (Fletcher, Creamer, & Forbes, 2010).
Although it is difficult to compare these numbers due
to the varying definitions of improvement and recovery
that were used, the message remains clear in that a
substantial group of patients does not benefit from a
TFP or still suffers from residual symptoms after treat-
ment (Bradley et al., 2005).
One of the factors that is indicated as being negatively
associated with reduced treatment results is dissociation.
It has been argued that dissociation could hinder fear
activation, which is considered to be a key mechanism of
successful PTSD treatment (Cooper, Clifton, & Feeny,
2017; Ebner-Priemer et al., 2009; Littel, Remijn, Tinga,
Engelhard, & van den Hout, 2017). In line with this
reasoning, experts in the field of dissociation state that
TFPs can lead to an ‘increase in PTSD and related symp-
toms, including dissociation, emotion dysregulation, and
an increase in the patient’s overall distress and functional
impairment’ (Lanius et al., 2010, p. 644). Indeed, a study
among 137 individuals who had just recently been
exposed to a traumatic event showed that dissociation
prior to the first session of an early intervention (consist-
ing of three 60-min sessions across three weeks) was
associated with a reduced treatment response (Price,
Kearns, Houry, & Rothbaum, 2014). Likewise, in a sam-
ple of 244 veterans who had received a standardized six-
week residential treatment programme for PTSD consist-
ing of individual trauma-focusedCBT and group therapy
sessions, Murphy and Busuttil (2015) found that higher
levels of baseline dissociation were associated with worse
post-treatment PTSD outcomes. Further, a study that
evaluated data from 69 PTSD patients receiving EMDR
therapy showed dissociation, as indexed by the
Dissociation Experiences Scale, to be a significant pre-
dictor of non-response (Bae, Kim, & Park, 2016).
However, in the latter study patients were given only
four sessions of EMDR, which is commonly regarded as
an inadequate dosage of active treatment. This might
have negatively influenced the effects of patients with
the dissociative subtype, who usually have more severe
PTSD symptoms and are therefore in need of the full
dosage of trauma-focused treatment. Other authors refer
to opposing findings, suggesting that dissociative symp-
toms alleviate due to TFP treatment (Resick, Suvak,
Johnides, Mitchell, & Iverson, 2012; van Minnen,
Harned, Zoellner, & Mills, 2012), stating that patients
with dissociative symptoms benefit similarly from TFP
treatment compared to patients without these symptoms
(Hagenaars, van Minnen, & Hoogduin, 2010).
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In DSM-5, the ‘dissociative subtype of PTSD’ (DS)
was included in the diagnostic criteria of PTSD diag-
nosis (American Psychiatric Association, 2013). This
diagnostic category pertains to a subgroup of PTSD
patients who exhibit key dissociative phenomena, i.e.
depersonalization (the experience of feeling detached
from one’s body) and/or derealization (the experience
of unreality of surroundings). The decision to add DS
to DSM-5 was partly based upon theoretical assump-
tions (Lanius, Brand, Vermetten, Frewen, & Spiegel,
2012; Wolf et al., 2012; Wolf, Miller, Harrington, &
Reardon, 2012) and empirical evidence suggesting
that individuals with DS show increased activation
in the rostral anterior cingulate cortex and the medial
prefrontal cortex (Lanius et al., 2010). This would
lead to emotional overmodulation, thereby prevent-
ing emotional engagement with trauma-related mate-
rial, making individuals with DS less likely to respond
to TFPs. Accordingly, it is assumed that individuals
experiencing depersonalization and/or derealization
benefit most from skills training in affective and
interpersonal regulation prior to TFP (Lanius et al.,
2012). A study using a sample of 284 female active
duty service members and veterans undergoing either
prolonged exposure or present-centred therapy
(Wolf, Lunney, & Schnurr, 2016) found that PTSD
patients with DS showed poorer treatment response
compared to PTSD patients who did not fulfil the
criteria of DS. However, the magnitude of this effect
was very small, which led the authors to conclude
that exposure therapy is indeed effective in dissocia-
tive symptoms. These findings are consistent with the
results of a secondary analysis of a treatment study of
narrative exposure therapy (NET) and treatment as
usual among severely traumatized asylum seekers and
refugees, which showed that DS did not substantially
moderate the treatment outcomes (Halvorsen,
Stenmark, Neuner, & Nordahl, 2014). A recent
study replicated these findings by generalizing the
results to individuals with a severe psychiatric condi-
tion and performing a secondary analysis of a rando-
mized clinical trial comparing prolonged exposure
with EMDR therapy among PTSD patients with psy-
chosis (van den Berg et al., 2015; van Minnen et al.,
2016). Patients with and without DS showed a similar
decrease in PTSD symptoms with large effect sizes
observed in both groups. Because previous research
on the effect of dissociation in treatment outcomes
pertained to specific trauma populations (i.e. female
veterans, refugees, psychotic patients), the results
need further replication in a more heterogeneous
sample in terms of patients and traumatic events.
The purpose of the present study was, therefore, to
determine the impact of dissociation on PTSD treat-
ment outcome using a sample of both women and men
with PTSD as a result of a wide variety of traumatic
events and suffering from multiple comorbidities. These
patients underwent a short, highly intensive treatment
programme consisting of two first-line TFPs for PTSD
(prolonged exposure and EMDR therapy) which were
applied without a preceding stabilization phase, and
without explicitly addressing dissociation during treat-
ment. Based upon the assumptions underlying the deci-
sion to include DS within DSM-5, it was hypothesized
that patients who met the criteria for DS would respond
significantly more poorly than those who did not. To
our knowledge, previous studies did not examine
whether the symptoms of DS are amendable to change.
Therefore, an additional aim was to determine the
degree of loss of DS diagnostic criteria following
trauma-focused treatment.
2. Methods
2.1. Participants
Participants were patients who were enrolled in an inten-
sive treatment programme for PTSD between August
and December 2016 at the Psychotrauma Expertise
Centre (PSYTREC) in the Netherlands. All of them
were referred for treatment by their general practitioner,
psychiatrist or another mental health care centre. The
only service referral criterion was a (probable) diagnosis
of PTSD. No preparatory interventions were offered
beforehand. Less than 10% of the referred patients did
not attend the first intake session, about half of them
rescheduled the appointment though, indicating that the
intensive treatment programme was acceptable for
patients. A total of 182 patients entered treatment, of
whom 177 (97.3%) gave informed consent for participa-
tion in clinical research. Three patients (1.7%) dropped
out of treatment. These individuals were excluded from
the analysis. For six participants, the post-treatment
scores of the primary outcome measure, the Clinician
Administered PTSD Scale (CAPS), were lacking. This
resulted in a sample of 168 participants. Of the total
sample, 146 (86.9%) had received prior psychological
treatment; of them, 78 (46.4%) already received EMDR-
therapy sessions and five (3.0%) prolonged exposure
therapy prior to engaging in the intensive treatment
programme. Table 1 provides an overview of the sample
characteristics of the 168 participants.
2.2. Procedure
Pre-treatment assessment took place at the treatment
centre, using the Dutch versions of CAPS (Blake
et al., 1995; Hovens, Luinge, & van Minnen, 2005)
and Mini International Neuropsychiatric Interview
(MINI; Overbeek, Schruers, & Griez, 1999; Sheehan
et al., 1998). Additionally, participants were asked to
fill out the PTSD Symptom Scale Self-Report ques-
tionnaire (PSS-SR; Foa, Riggs, Dancu, & Rothbaum,
1993) and the modified Interview for Traumatic
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Events in Childhood (ITEC; Lobbestael, Arntz,
Harkema-Schouten, & Bernstein, 2009). Inclusion cri-
teria were: (1) being at least 18 years old, (2) having a
diagnosis of PTSD according to the DSM-IV-TR
(APA, 2000) as established with CAPS, (3) having
sufficient knowledge of the Dutch language to be
able to complete the assessments, (4) not being con-
victed for a sexual assault and (5) not having a
history of a suicide attempt in the three months
prior to treatment. If these criteria were met, the
patient was invited to sign a treatment contract and
informed consent for research purposes. The study
was performed in accordance with the precepts and
regulations for research as stated in the Declaration
of Helsinki and the Dutch Medical Research on
Humans Act (WMO) concerning scientific research.
That is, all data were collected using the standard
assessment instruments and routine outcome moni-
toring procedure of the PSYTREC mental health cen-
tre, the study lacked random allocation and no
additional physical infringement of the physical and/
or psychological integrity of the individual was to be
expected.
After the intake sessions, the intensive eight-day
treatment programme started. Nine days after
treatment, patients returned to the centre for the
post-treatment assessment, consisting of CAPS and
PSS-SR. Assessors of both pre-treatment and post-
treatment measures were blind to the study
hypotheses.
2.3. Treatment
Treatment was provided in 2 × 4 consecutive days.
Following the first four days of treatment patients
went home for three days, and then returned to the
clinic for the last four days of treatment. Each treat-
ment day consisted of a morning session (i.e. 90 min-
utes of individual prolonged exposure therapy), an
afternoon session (90 minutes of individual EMDR
therapy) and an evening programme (two hours of
psycho-education about PTSD), with six hours of
sport activities in between.
In this study, prolonged exposure and EMDR ther-
apy were combined. Given research suggesting that
prolonged exposure and EMDR have different under-
lying working mechanisms (Lee, Taylor, &
Drummond, 2006), we considered it likely that such
a combination would increase the proportion of
patients that responds to trauma-focused treatment
and reduce the drop-out rate.
The purpose of psycho-education was to provide
insight in PTSD symptoms, triggers and avoidance
behaviours. No exercises regarding emotion regula-
tion, relaxation or grounding were offered during
these psycho-education sessions.
The sport activities were aimed at activation and
were implemented because of its strong empirical sup-
port as an intervention for physical and mental health
conditions in general, and for enhancement of trauma-
focused treatment in PTSD specifically (Powers et al.,
2015; Rosenbaum et al., 2015). Exercises within the
sport programme varied from low to high intensity
and were both indoor and outdoor (e.g. mountain
biking, hiking, obstacle course, archery).
Therapy sessions were carried out by clinical psy-
chologists who were trained in exposure therapy and
EMDR therapy, and had received additional in-house
training sessions specifically designed for this inten-
sive treatment programme. Patients were treated by
multiple, rotating therapists and their sessions and
progress were discussed in daily meetings, which
also contributed to assuring adherence to the treat-
ment protocols.
EMDR therapy was provided according to guide-
lines by Shapiro (2001) and the Dutch version of the
EMDR standard protocol (de Jongh & Ten Broeke,
2013), comprising an eight-phase psychotherapeutic
approach. In EMDR therapy, patients envision the
currently most distressing part of a traumatic event
while burdening their working memory capacities by
visually following finger movements of the therapist.
To maximize the working memory load, therapists
Table 1. Sample characteristics (N = 168).
DS No DS
Mean age (SD) 36.05 (11.32) 38.78 (10.78)
Sex (% female) 81.6% 66.9%
PTSD severity (CAPS)
Mild (score < 45) 0% 0%
Moderate (score 45–64) 2.6% 1.5%
Severe (score ≥ 65) 97.4% 98.5%
Trauma exposure
Childhood sexual abuse 42.1% 43.8%
Adult sexual abuse 34.2% 28.5%
Physical abuse 73.7% 84.6%
Work-related trauma 26.3% 22.3%
Accidents, disasters or war violence 21.1% 27.7%
Comorbidity (MINI)
Depressive episode 57.9% 72.3%
Dysthymia 55.3% 47.7%
Hypomania 2.6% 2.3%
Mania 5.3% 5.4%
Panic disorder 18.4% 17.7%
Agoraphobia 13.2% 23.1%
Social phobia 18.4% 36.2%
Obsessive compulsive disorder 7.9% 13.8%
Alcohol dependency 10.5% 17.7%
Suicidal risk (MINI)
None 26.3% 19.2%
Low 15.8% 32.3%
Moderate 15.8% 18.5%
High 28.9% 27.7%
Percentages of Comorbidity and Trauma exposure do not add up to
100%, since individuals could have experienced multiple types of
trauma and could suffer from multiple comorbidities. Comorbidity
and Suicidal risk were assessed using the Mini-International
Neuropsychiatric Interview (MINI), type of trauma was determined
using a modified version of the Interview for Traumatic Events in
Childhood (ITEC) and severity of PTSD symptoms was indexed
using the Clinician Administered PSTD Scale (CAPS). Work-related
trauma covers trauma exposure during military service, service in a
police force, as a fire-fighter or whilst working in the mental
health care.
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were allowed to add additional stimuli if needed, such
as a light bar, clicking sounds and tactile stimulation
via a pulsator. Cognitive interweaves, as described by
Shapiro (2001), could also be employed when needed.
The prolonged exposure sessions followed a mod-
ified version of Foa’s prolonged exposure protocol
(Foa et al., 2007). As outlined in Foa’s protocol,
patients are exposed to the memories of traumatic
events by means of imagining the traumatic event as
vividly as possible and describing it aloud in the
present tense and in detail. The processing of the
traumatic memories is also included. Because of the
intensive treatment format, no homework assign-
ments were given. Sessions were therefore also not
recorded. No in-vivo homework assignments were
given. However, in vivo material, such as pictures,
sound fragments, clothes and other objects that
reminded the patient of the traumatic event, were
incorporated into the prolonged exposure sessions.
2.4. Measurements
As a primary outcome measure, clinician-rated PTSD
symptom severity was measured using the Dutch
version of CAPS (Hovens et al., 2005), a well-vali-
dated semi-structured diagnostic interview (Hovens
et al., 1994; Weathers, Keane, & Davidson, 2001). It
comprises the 17 DSM-IV PTSD symptoms – clus-
tered in three subscales (Re-experiencing, Avoidance,
Hyperarousal) – measured over the past month using
5-point scales for frequency (ranging from 0 = ‘never’
to 4 = ‘almost daily’) and intensity (ranging from
0 = ‘none’ to 4 = ‘extremely’). Total severity scores
were computed by adding up all frequency and inten-
sity ratings across the 17 items (ranging from 0 to
136). Total severity scores of ≥ 65 indicated severe
PTSD, scores between 45 and 65 indicated moderate
symptoms of PTSD, and scores below 45 indicated
mild or no symptoms of PTSD (Weathers et al.,
2001). CAPS was administered at pre- and post-treat-
ment. CAPS included two separate items representing
the symptoms of the dissociative subtype: derealiza-
tion and depersonalization. Using the conservative
score rule of frequency ≥ 2 and severity ≥ 2 on at
least one of these items, patients were classified as
meeting or not meeting the criteria of the dissociative
subtype (as per Nicholson et al., 2015).
Self-reported severity of PTSD symptoms was mea-
sured with PSS-SR (Arntz, 1993; Foa et al., 1993), a 17-
item questionnaire that assesses the severity of PTSD
symptoms in the past week based on the diagnostic
criteria of the DSM–IV. PTSD symptom severity is
rated on 4-point Likert scales from 0 (not at all) to 3
(very much) and scores per symptom add up to a total
severity score ranging from 0 to 51, with higher scores
suggesting higher PTSD severity. The internal consis-
tency is considered satisfactory and the concurrent
validity is considered good (Foa et al., 1993). PSS-SR
was administered on the first day of treatment and at
post-treatment.
The Dutch version of MINI (Overbeek et al., 1999;
Sheehan et al., 1998) was used to establish comorbid-
ity, i.e. additional DSM-IV axis-I disorders. MINI is a
validated structured interview that has proven to be a
reliable classification instrument (Lecrubier et al.,
1997; Sheehan et al., 1998). Items are dichotomous
(‘yes’ or ‘no’) and represent DSM-IV criteria.
Individuals were diagnosed when they met sufficient
criteria. MINI was also used to determine suicidal
risk, which was categorized as low, moderate or high.
2.5. Statistical analyses
IBM SPSS Statistics for Windows (version 20) was
used to perform a mixed-design ANOVA. The dis-
sociative subtype of PTSD (DS) was used as dichot-
omous independent variable, and change in scores
on both CAPS (pre- and post-treatment) and PSS-
SR (at day 1 and post-treatment) as the dependent
variable. Person mean imputation was performed
when the percentage of missing data on the total
number of items of a measure did not exceed 10%
(Downey & King, 1998; Hawthorne & Elliott, 2005).
If this was not the case, participants were excluded
from analyses (Cohen, Cohen, West, & Aiken,
2003). For this reason, 10 participants were excluded
in the analysis of the primary outcome measure
CAPS, and 18 participants were excluded from
PSS-SR analysis. To compare baseline differences
in demographic variables (age, gender, type of
trauma) between dissociative subtype conditions,
chi square analyses were conducted. Cohen’s d effect
sizes were interpreted according to Cohen’s (1988)
rules of thumb. To assess changes in the presence of
the dissociative subtype before and after treatment, a
McNemar test was performed, a method suitable for
comparison of paired nominal data. Paired samples
t-tests were conducted to compare pre-treatment
and post-treatment mean scores on the dissociation
items. Preliminary analyses indicated no violations
of the assumption of homogeneity of variance.
3. Results
3.1. Sample characteristics
Of all patients, 38 (22.6%) met DSM-5 criteria for DS.
Of the nine patients who were not included in the
analyses due to incomplete data or premature drop-
out, eight did not meet the criteria of DS. For the
other participant, pre-treatment data was missing.
Patients with and without DS did not differ in age
(t(166) = 1.36, p = .177) or gender (χ2(1) = 3.02,
p = .082). Also, no differences were found regarding
EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY 5
type of trauma exposure, i.e. sexual abuse (χ2
(1) = 1.33, p = .249), physical abuse
(χ2 (1) = 2.75, p = .097), work related traumas
(χ2 (4) = 4.03, p = .402), and accidents, disasters or
war violence (χ2 (1) = 0.71, p = .399) were equally
prevalent in both groups. Sample characteristics
regarding comorbidities and PTSD severity can be
found in Table 1.
3.2. Overall treatment outcome
A mixed-design ANOVA with CAPS total scores as
dependent variable showed a significant, main effect of
time, F(1, 166) = 259.11, p < .001, n2p = .61, see also
Table 2. Employing Schnurr and Lunney’s (2016) cate-
gories for clinical meaningful outcome, 84.1% of the
participants showed response, 55.3% lost their PTSD
diagnosis, and PTSD was in remission for 27.1% of the
participants. A mixed-design ANOVA with the PSS-
SR-scores as outcome variable also indicated a signifi-
cant main effect of time, F(1, 156) = 164.61, p < .001,
n2p = .51, see Table 2.
3.3. Impact of dissociative subtype on patients’
CAPS scores
The mixed-design ANOVA with CAPS total scores as
dependent variable showed a significant main effect
of group, F(1, 166) = 7.46, p = .007, n2p = .04.
However, the effect size was small; that is, the
between-group differences in symptom severity were
only for 4% associated with the presence or absence
of DS. No interaction effect was found, F(1,
166) = 2.47, p = .118, n2p = .02, which means that,
albeit overall patients with DS scored significantly
higher on both pre- and post-assessments than
those without DS, patients with and without DS
showed equal, significant reductions in CAPS scores
over the course of treatment. Large effect sizes were
achieved for PTSD symptom reduction on CAPS for
patients both with DS (Cohen’s d = 1.73) and without
(Cohen’s d = 2.12). The effect-size of the difference
between the two groups was small (Cohen’s d = 0.43).
Figure 1 illustrates the progression of mean total
CAPS scores over time for both groups.
3.4. Impact of dissociative subtype on patients’
PSS-SR scores
The mixed-design ANOVA of PSS-SR scores showed
a significant main effect of group, F(1, 156) = 5.96,
p = .016, n2p = .04. However, this effect was small; that
is, the presence or absence of DS explained the
between-group differences in symptom severity for
only 4%. No interaction effect of time by group was
found, F(1, 156) = 1.24, p = .268, n2p = .01. Hence,
despite the overall relatively higher pre- and post-
treatment PSS-SR scores of those with DS, equal,
Table 2. Mean pre-treatment and post-treatment CAPS scores
and PSS-SR scores and outcome of mixed-design ANOVA.
Measure Subset
Pre-treatment
score M (SD)
Post-treatment
score M (SD) p ηp2
CAPS
Total (N = 168) 93.66 (12.81) 44.23 (32.38) < .001 .61
DS (N = 38) 97.31 (11.29) 54.97 (32.74)
No DS (N = 130) 92.60 (13.07) 41.09 (31.71)
PSS-SR
Total (N = 158) 35.99 (6.73) 18.19 (13.32) < .001 .51
DS (N = 36) 37.63 (6.77) 22.11 (13.11)
No DS (N = 122) 35.49 (6.67) 17.03 (13.21)
CAPS = Clinician Administered PTSD Scale, PSS-SR = PTSD Symptom
Scale Self-Report; ηp2 = partial eta squared.
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Figure 1. Mean total CAPS scores (A) and mean total PSS-SR scores (B) for patients with and without the dissociative subtype of
PTSD.
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significant reductions in PSS-SR scores were achieved
throughout treatment for patients both with and
without DS. Large effect sizes were achieved for
PTSD symptom reduction on PSS-SR for patients
both with DS (Cohen’s d = 1.49) and without
(Cohen’s d = 1.76). The effect-size of the difference
between the two groups regarding PSS-SR scores
proved to be small (Cohen’s d = 0.38). Figure 1
illustrates the progression of mean total PSS-SR
scores over time for both groups.
3.5. Change in the presence of the dissociative
subtype
Of the 38 participants who met the criteria for DS,
26 (68.4%) no longer met these criteria following
treatment. For those who initially met the criteria
for DS, depersonalization was significantly less
frequent (t(37) = 3.68, p = .001) and less intense
(t(37) = 5.32, p < .001) after completing the treat-
ment programme. Furthermore, derealization also
significantly decreased in frequency (t(37) = 2.60,
p = .013) and intensity (t(37) = 4.48, p < .001), see
also Table 3.
4. Discussion
The present study examined whether the presence of
DS has a detrimental effect on the outcome of a first-
line trauma-focused treatment programme. Even
though most patients in this study suffered from
severe PTSD and multiple comorbidities, overall, a
large and significant reduction in PTSD symptoms
was achieved after treatment. More specifically, more
than 80% showed a clinical meaningful response,
whereas more than half of the patients lost their
PTSD diagnosis. Over the course of treatment, the
severity scores of both DS and non-DS groups
decreased from severe PTSD to mild or no PTSD,
as indexed by both clinician-administered and self-
report measures. Most importantly, the decline in
PTSD symptom severity was similar for individuals
with DS and for those without DS. Hence, the results
of the present study do not provide support for the
notion that the presence of DS has a negative impact
on the outcome of first-line, trauma-focused treat-
ments for those suffering from severe PTSD.
The present findings are at odds with prevailing
theoretical assumptions in the trauma field that indi-
viduals who experience a high level of state dissocia-
tion would do worse in trauma-focused treatments
than other groups of patients (Lanius et al., 2010,
2012). It could be argued that physical activity is a
useful type of ‘stabilizing work’, in that it might help
patients to re-regulate if they become dissociated or
overly emotional during or after trauma focused
treatment. For instance, there is evidence indicating
that sport has a positive effect on both symptoms of
PTSD and depressive symptoms, and that physical
activity might play a role in the multidisciplinary
treatment of PTSD (Rosenbaum et al., 2015).
Although further research about the specific role
that physical activity plays in our treatment pro-
gramme is needed, it should be noted that the results
are consistent with a number of recent studies that
did not incorporate any physical activity within their
treatment. For example, those with women under-
going Cognitive Processing Therapy (CPT; Resick
et al., 2012), female veterans and active duty service
members undergoing Prolonged Exposure (PE; Wolf
et al., 2016), individuals suffering from psychosis of
schizophrenia who were treated with PE or EMDR
Therapy (van Minnen et al., 2016) and asylum see-
kers and refugees who received NET (Halvorsen
et al., 2014). The latter study demonstrated that 50%
of the patients with severe derealization, and 50%
showing severe depersonalization at pre-treatment,
achieved clinically significant change in their CAPS
total scores following treatment (Halvorsen et al.,
2014). Interestingly, our results mimicked the find-
ings of van Minnen et al. (2016) who also found that
individuals with DS reported significantly greater
PTSD symptom severity at the beginning, while this
difference remained constant throughout treatment.
To this end, it should be noted that, on average, the
patients with DS in the current study still displayed a
moderate level of PTSD symptoms after treatment.
This suggests that the presence of dissociative symp-
toms demands a longer treatment duration or other
treatment approaches to compensate for a higher
initial PTSD severity, for example by specifically
addressing patients’ fears of decompensation as a
way to circumvent the occurrence of dissociative
phenomena.
An intriguing finding of the present study is that,
after treatment, a majority of patients with DS did
not meet the criteria of this condition anymore, albeit
dissociative symptoms were not explicitly addressed
Table 3. Changes in mean scores on the depersonalization
and derealization items of CAPS for those who initially met
the criteria for DS.
Pre-
treatment M
(SD)
Post-
treatment M
(SD) P Cohen’s d
Depersonalization
frequency
1.67 (1.35) 0.67 (1.22) .001 0.78
Depersonalization
intensity
1.75 (1.32) 0.50 (0.91) < .001 1.10
Derealization
frequency
1.72 (1.47) 0.89 (1.39) .013 0.58
Derealization
intensity
1.64 (1.40) 0.58 (0.91) < .001 0.90
When the scoring rule of frequency ≥ 2 and intensity ≥ 2 was met on at
least one of the dissociation items, participants were classified as
meeting the criteria for the dissociative subtype.
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during treatment. This is in line with previous clinical
trials, in which trauma-focused treatments were suc-
cessful in reducing PTSD symptoms and dissociative
symptoms concurrently (Hagenaars, van Minnen,
Hoogduin, & Verbraak, 2009; Resick et al., 2012;
van Minnen et al., 2016; Wolf et al., 2016). The
large treatment-related change in the presence of
DS, and that DS and non-DS patients showed similar
levels of improvement after trauma-focused therapy,
might have implications for both the reliability and
the validity of this subtype of PTSD. This is particu-
larly relevant in light of the suggestion that the aetiol-
ogy of DS might be based upon distinct genetic
vulnerabilities (Wolf et al., 2014), suggesting DS to
be a trait rather than a state dependent subtype, as
our data imply.
Strengths of the current study include the use of both
clinician-administered and self-administered PTSD
measures, and the diversity of the sample regarding
gender, age and nature of the traumatic experiences.
This study also faced several limitations. Firstly, insuffi-
cient follow-up data was available for analyses due to
the relatively short existence of the treatment centre.
Clearly, future studies should include follow-up data to
be able to examine the course of the dissociative symp-
toms long after treatment because between-group dif-
ferences might become apparent during follow-up
(Cloitre et al., 2010). Secondly, the sample was dichot-
omized into either fulfilling DSM-5 criteria of a disso-
ciative subtype or not, whereas no separate measures
pertaining to dissociative features were included in the
current study. Although derealization and depersonali-
zation were indexed using the same items fromCAPS as
used in most previous research (Armour, Karstoft, &
Richardson, 2014; Halvorsen et al., 2014; Wolf et al.,
2012, 2016), the inclusion of a more elaborate measure
of dissociative phenomena, such as the Multiscale
Dissociation Inventory (Briere, 2002), would allow for
a more in-depth analysis of gradations and alterations
in dissociative symptoms. Thirdly, it could be consid-
ered a methodological weakness to not include an ana-
lysis on the follow-up data. However, the primary aim
of the study was not to show that the intensive treat-
ment programme was effective, but rather to examine
whether DS moderated the treatment outcome at post-
treatment. In some of the referenced studies in our
introduction, follow-up results were included, and in
none of these cases the effects differed from the post-
treatment results, indicating that the results obtained at
post-treatment are highly stable across time (e.g.
Hagenaars et al., 2010; Resick et al., 2012). Also, study-
ing only post-treatment outcomes offers the advantage
of analysing moderating effects in a highly controlled
treatment period, because we were able to constantly
monitor and check that no other treatment elements
than intended were added. In contrast, studying mod-
erators on follow-up effects is less controlled, since
patients may be undergoing additional interventions,
including stabilizing treatments following the conclu-
sion of the trauma-focused treatment. Fourth, our pro-
longed exposure protocol did not include homework
assignments. Although our results are in line with find-
ings from studies that used regular prolonged exposure
including homework, we do not know how this may
have influenced our positive results. Finally, the study
lacked randomization, which prohibits meaningful con-
clusions regarding the superiority of either intensive,
trauma-focused treatment or a phase-based treatment
approach (see de Jongh et al., 2016).
In conclusion, besides evidence supporting the
effectiveness of a short, intensive treatment pro-
gramme consisting of a combination of two trauma-
focused therapies without a prior stabilization phase,
the present study results provide further support for
the notion that the presence of DS does not moderate
the outcome of trauma-focused treatments for PTSD.
To this end, the results converge to suggest that
excluding individuals with DS from trauma-focused
treatment, or to include an initial stabilization phase
to train emotion regulation skills prior to trauma-
focused treatment, is generally not warranted (de
Jongh et al., 2016; van Minnen, Arntz, & Keijsers,
2002; van Minnen et al., 2012).
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